Pages that link to "Q48399841"

The following pages link to Regional distribution of subtypes of nicotinic receptors in human brain and effect of aging studied by (+/-)-[3H]epibatidine (Q48399841):

Displaying 41 items.

• The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function (Q24308763) (← links)
• Mammalian nicotinic acetylcholine receptors: from structure to function (Q24647069) (← links)
• Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain (Q28139981) (← links)
• Neuronal nicotinic receptors in the human brain (Q28141480) (← links)
• Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease (Q30497749) (← links)
• Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications. (Q32077061) (← links)
• Nicotine and its interaction with beta-amyloid protein: a short review (Q32077110) (← links)
• Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique. (Q33195555) (← links)
• In vitro imaging techniques in neurodegenerative diseases (Q33275232) (← links)
• Development of ligands for in vivo imaging of cerebral nicotinic receptors (Q34002779) (← links)
• Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum (Q34142038) (← links)
• Nicotinic receptors in human brain: topography and pathology (Q34156143) (← links)
• Nicotinic receptor subtypes in human brain related to aging and dementia (Q34346561) (← links)
• Decreased response to acetylcholine during aging of aplysia neuron R15. (Q35081052) (← links)
• Zolpidem reduces the blood oxygen level-dependent signal during visual system stimulation (Q35159139) (← links)
• Nicotinic excitatory postsynaptic potentials in hippocampal CA1 interneurons are predominantly mediated by nicotinic receptors that contain α4 and β2 subunits (Q35381846) (← links)
• Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers (Q36076416) (← links)
• Age-related decline in nicotinic receptor availability with [(123)I]5-IA-85380 SPECT. (Q36469337) (← links)
• Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey (Q36994843) (← links)
• Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction (Q37525085) (← links)
• Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging (Q38810544) (← links)
• Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. (Q43686156) (← links)
• Nicotine-induced alterations in the expression of nicotinic receptors in primary cultures from human prenatal brain. (Q43715530) (← links)
• Impact of intravenous nicotine on BOLD signal response to photic stimulation (Q44009027) (← links)
• [125I]Epibatidine-labelled nicotinic receptors in the extended striatum and cerebral cortex: lack of association with serotonergic afferents (Q44203412) (← links)
• Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression. (Q44234633) (← links)
• Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. (Q44573142) (← links)
• Quantification of nicotinic acetylcholine receptors in human brain using [123I]5-I-A-85380 SPET. (Q44605597) (← links)
• Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. (Q44672177) (← links)
• Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum (Q44726532) (← links)
• The effects of the alpha2-adrenergic receptor agonists clonidine and rilmenidine, and antagonists yohimbine and efaroxan, on the spinal cholinergic receptor system in the rat. (Q44839898) (← links)
• Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18 F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways. (Q46311520) (← links)
• Imaging α4β2 Nicotinic Acetylcholine Receptors (nAChRs) in Baboons with [18F]XTRA, a Radioligand with Improved Specific Binding in Extra-Thalamic Regions. (Q48094212) (← links)
• Quantification of cerebral nicotinic acetylcholine receptors by PET using 2-[18F]fluoro-A-85380 and the multiinjection approach (Q48159280) (← links)
• Neuronal nicotinic receptor deficits in Alzheimer patients with the Swedish amyloid precursor protein 670/671 mutation (Q48275764) (← links)
• Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study (Q48481156) (← links)
• 18F-XTRA PET for enhanced imaging of the extrathalamic α4β2 nicotinic acetylcholine receptor. (Q51766239) (← links)
• Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. (Q53237083) (← links)
• Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease (Q73222827) (← links)
• Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging (Q74170585) (← links)
• Smoking and Aging Clinical Implications Part I: Health and Consequence (Q79122779) (← links)